Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of PROGRAF (twice-daily tacrolimus) vs ADVAGRAF (modified release tacrolimus) in stable liver transplant recipients
KCT0000478Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2012
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in liver transplant recipient (LTR), sponsored by Astellas Pharma. Started Jul 2012; status: completed.
02
Drugs
tacrolimus
03
Conditions
liver transplant recipient (LTR)
Beyond the preview
Go deeper on KCT0000478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000478.